Smoking and Tobacco News

Primary care physicians were frequently not their patients’ main source of information when it came to e-cigarette use, according to findings recently published in the Journal of the American Board of Family Medicine.

More than 90% of teenagers living in economically disadvantaged areas in and around San Francisco had 1-butanol urine screens that showed exposure to tobacco, according to findings recently published in Cancer, Epidemiology, Biomarkers and Prevention.

Smoking cigars and pipes are associated with a significantly increased risk for death from tobacco-related cancers, as well as cardiovascular causes, according to research published in JAMA Internal Medicine.

Although e-cigarettes are less hazardous than combustible cigarettes, they emit potentially harmful chemicals and should not be used as a smoking cessation aid, according to a commentary published in Annals of Internal Medicine.

Elevated incidence of CHD attributable to smoking was less prominent in those with a genetic predisposition to CHD than in those without it, according to a study published in Circulation: Genomic and Precision Medicine.

The FDA’s Tobacco Products Scientific Advisory Committee recently ruled that several of the claims made by Philip Morris for the intention of using in its marketing and labelling its IQOS cigarette were invalid.

Patients taking Chantix had a heightened risk for hospitalizations and ED visits due to adverse cardiovascular events, according to findings published in the American Journal of Respiratory and Critical Care Medicine.

Approximately 69% of individuals who ever tried a cigarette progressed — at least briefly —to daily smoking, according to a study published in Nicotine and Tobacco Research.

Regular consumption of tomatoes and fruits, particularly apples, may delay the natural decline in lung function in adults, as well as restore function in former smokers, according to findings published in the European Respiratory Journal.

Metabolism-informed care — a treatment strategy that matches normal metabolizers with a non-nicotine-based therapy such as Chantix and slow nicotine metabolizers with nicotine replacement therapy patch — was an acceptable option for patients who wanted to stop smoking, according to findings published in Nicotine & Tobacco Research.